⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LEXX News
Lexaria Bioscience Corp. Common Stock
Lexaria Announces New R&D Plans for 2026
accessnewswire.com
LEXX
Lexaria Announces Positive Final Results From Human Pilot Study #5
accessnewswire.com
LEXX
Lexaria Awarded Six Additional Patents
accessnewswire.com
LEXX
THE FOCUS DOCTRINE: 5 Assets Securing the 2026 Biological Choke Point
globenewswire.com
LEXX
WST
NAGE
PM
Lexaria Releases Annual Letter from the CEO
accessnewswire.com
LEXX
LEXXW
Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4
accessnewswire.com
LEXX
LEXXW
Primary Endpoint Successfully Achieved in Lexaria's Phase 1b Study GLP-1-H24-4
accessnewswire.com
LEXX
LEXXW
Lexaria Bioscience Corp. Announces Closing of $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
accessnewswire.com
LEXX
New Lexia Survey Reveals COVID-Era Kindergarteners Enter School With Weaker Literacy, Attention, and Social-Emotional Skills
businesswire.com
LEXX
CMBM
Lexaria Bioscience Corp. Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
accessnewswire.com
LEXX